CD19 and pneumocystosis: Given the percentages of CD3+, CD4+, and CD8+ T cells were significantly lower in PJP patients than in non-PJP controls, the percentages of CD19+ B and CD3-CD56+ NK cells were relatively significantly higher in PJP patients in comparison to non-PJP controls.